A detailed history of Farallon Capital Management LLC transactions in Geron Corp stock. As of the latest transaction made, Farallon Capital Management LLC holds 16,837,000 shares of GERN stock, worth $71.1 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
16,837,000
Holding current value
$71.1 Million
% of portfolio
0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $29 Million - $47.6 Million
9,342,000 Added 124.64%
16,837,000 $71.4 Million
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $13.1 Million - $25.8 Million
7,495,000 New
7,495,000 $24.7 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.